Evidence map›Paper›PMID 32998039›Full record

ArticleThe Journal of infection2021

The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trials.

Thibault Sixt, Florian Moretto, Hervé Devilliers, Maroua Abdallahoui, Isabelle Eberl, Thomas Rogier, Michel Duong, Arnaud Salmon-Rousseau, Sophie Mahy, Marielle Buisson and 5 more

Open access · hybridAbstract readLetterComment
In one paragraph

Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?International journal of environmental research and public health · 2022
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Thibault SixtInfectious Diseases Department, Dijon University Hospital, France.
Florian MorettoInfectious Diseases Department, Dijon University Hospital, France.
Hervé DevilliersInternal medicine department, Dijon University Hospital, France; INSERM CIC 1432, module plurithématique, University of Burgundy, Dijon, France.
Maroua AbdallahouiInternal medicine department, Dijon University Hospital, France.
Isabelle EberlInfectious Diseases Department, Dijon University Hospital, France.
Thomas RogierInternal medicine department, Dijon University Hospital, France.
Michel DuongInfectious Diseases Department, Dijon University Hospital, France.
Arnaud Salmon-RousseauInfectious Diseases Department, Dijon University Hospital, France.
Sophie MahyInfectious Diseases Department, Dijon University Hospital, France.
Marielle BuissonInfectious Diseases Department, Dijon University Hospital, France.
Clementine EsteveInfectious Diseases Department, Dijon University Hospital, France.
Pascal ChavanetInfectious Diseases Department, Dijon University Hospital, France; INSERM CIC 1432, module plurithématique, University of Burgundy, Dijon, France.
François-Xavier CatherineInfectious Diseases Department, Dijon University Hospital, France.
Mathieu BlotInfectious Diseases Department, Dijon University Hospital, France; INSERM CIC 1432, module plurithématique, University of Burgundy, Dijon, France.
Lionel PirothInfectious Diseases Department, Dijon University Hospital, France; INSERM CIC 1432, module plurithématique, University of Burgundy, Dijon, France. Electronic address: lionel.piroth@chu-dijon.fr.
Maison des Sciences de l’Homme de Dijon · FRUniversité de Bourgogne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19AgedHospitalizationHumansSARS-CoV-2Severity of Illness IndexCOVID-19NEWS2PredictionSARS-CoV2Unfavourable event

Identifiers

PMID32998039
PMCPMC7521398
OpenAlexW3089067145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.